Please use this identifier to cite or link to this item:
https://dspace.uzhnu.edu.ua/jspui/handle/lib/44534| Title: | Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis |
| Authors: | Smolanka, V. Смоланка, Володимир Іванович O’Connor, Paul Wolinsky, Jerry S. Confavreux, Christian Comi, Giancarlo Kappos, Ludwig Olsson, Tomas P. Benzerdjeb, Hadj Truffinet, Philippe Wang, Lin Miller, Aaron Freedman, Mark S. Teriflunomide Multiple Sclerosis Oral (TEMSO) Trial Group |
| Issue Date: | 2011 |
| Publisher: | Massachusetts Medical Society |
| Citation: | O'Connor P. and others Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis / P. O'Connor, J. S. Wolinsky, C. Confavreux et al. // The New England Journal of Medicine. – Massachusetts Medical Society, 2011. Vol. 365. – P. 1293-1303. |
| Abstract: | Teriflunomide is a new oral disease-modifying therapy for relapsing forms of multiple sclerosis. Teriflunomide significantly reduced relapse rates, disability progression (at the higher dose), and MRI evidence of disease activity, as compared with placebo. (Funded by Sanofi-Aventis; TEMSO ClinicalTrials.gov number, NCT00134563.) |
| Type: | Text |
| Publication type: | Стаття |
| URI: | https://dspace.uzhnu.edu.ua/jspui/handle/lib/44534 |
| Appears in Collections: | Наукові публікації кафедри неврології, нейрохірургії та психіатрії |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Randomized Trial of Oral Teriflunomide.pdf | 598.26 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.